Analysis of 6 randomized controlled trials shows Atorvastatin improves kidney function.
Quoted:
“Conclusion - In patients at risk of or with cardiovascular disease, atorvastatin improved kidney function over time in a dose‐dependent manner. In the 3 treatment groups, kidney function improvement was strongly associated with lower cardiovascular risk.”
“In this post hoc analysis of 6 double‐blind randomized controlled cardiovascular outcome trials comprising 30,621 patients at risk of or having cardiovascular disease, we demonstrate that atorvastatin treatment improves kidney function over time in a dose‐dependent fashion.
Kidney function improvement, regardless of treatment arm, was associated with lower cardiovascular risk.”
“Our data suggest that both the cardio‐ and vasculoprotective efficacy of a pharmacological agent, such as atorvastatin, is reflected by the course of kidney function over time, indicating that this kidney‐related parameter might represent a surrogate end point for long‐term outcomes in cardiovascular risk patients.”


